Best Topics

Latest news by search query "covid 19 igm lgg ab test core technology"

Related News

Regina Covid - More tickets issued in connection with Regina COVID-19 public health order protest - globalnews.ca - county Park - Victoria, county Park
globalnews.ca
82%
877
More tickets issued in connection with Regina COVID-19 public health order protest
COVID-19.The Regina Police Service (RPS) said it monitored an anti-mask rally event protesting the public health orders with roughly 150 to 160 people in Victoria Park on April 24. Four tickets were issued to protesters for violations and more were pending, they said.
Regina Covid county Park Victoria, county Park covid-19 gatherings Connection
Alberta Health - Adriana Lagrange - Alberta Covid - Alberta Coronavirus - COVID-19: Alberta expands rapid testing to schools, oil and gas, meat-packing plants - globalnews.ca - Canada
globalnews.ca
51%
160
COVID-19: Alberta expands rapid testing to schools, oil and gas, meat-packing plants
COVID-19 rapid testing program to target asymptomatic people in various sectors across the province, including oil and gas, schools and banks.Students at two Calgary schools — one in the Calgary Board Education and one in the Calgary Catholic School District — will be involved in a pilot rapid testing program, which will begin as early as next week.Officials are hoping to learn if rapid tests will be an effective way of managing outbreaks, Education Minister Adriana LaGrange said Thursday. How rapid tests are being used to test for COVID-19 across Canada She said the tests will be done on staff and students who don’t have symptoms of the novel coronavirus.
Alberta Health Adriana Lagrange Alberta Covid Alberta Coronavirus Canada COVID-19 Alberta Coronavirus
Translate Bio-Sanofi Covid-19 vaccine elicits immune response in animals - pharmaceutical-technology.com - city Sanofi
pharmaceutical-technology.com
54%
420
Translate Bio-Sanofi Covid-19 vaccine elicits immune response in animals
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Translate Bio has reported that its Covid-19 vaccine candidate, being developed in collaboration with Sanofi, elicited immune response in early-stage animal studies. In a regulatory filing, Translate Bio cited Sanofi’s presentation slides, which revealed that three doses of the vaccine candidate triggered neutralising antibodies and T-cell responses in the preclinical tests.
city Sanofi covid-19 testing vaccine
Innovation’s Brilacidin shows promise in-vitro against Covid-19 - pharmaceutical-technology.com - Usa
pharmaceutical-technology.com
53%
855
Innovation’s Brilacidin shows promise in-vitro against Covid-19
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Innovation Pharmaceuticals has reported promising data from ongoing in-vitro testing of its Brilacidin at a US Regional Biocontainment Laboratory (RBL) to treat Covid-19. Data showed that Brilacidin has a high selectivity index (SI), used to compare the antiviral efficacy between investigational drugs.
Usa covid-19 testing information
UNION therapeutics licences drug technology from TFF Pharmaceuticals - pharmaceutical-technology.com
pharmaceutical-technology.com
58%
721
UNION therapeutics licences drug technology from TFF Pharmaceuticals
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.UNION therapeutics has signed an agreement with TFF Pharmaceuticals for an exclusive global licence to the latter’s Thin Film Freezing (TFF) technology platform used with niclosamide drug. The TFF platform is intended to improve the solubility and absorption of poorly water-soluble drugs, ideal for generating dry powder particles.
covid-19 information Government
US researchers say heparin may neutralise Covid-19 virus - pharmaceutical-technology.com - Usa
pharmaceutical-technology.com
80%
272
US researchers say heparin may neutralise Covid-19 virus
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Researchers at Rensselaer Polytechnic Institute in the US have said that the commonly available, US Food and Drug Administration (FDA)-approved drug heparin could effectively neutralise SARS-CoV-2, the virus that causes Covid-19. Based on research findings published in Antiviral Research, the drug may act as a decoy to prevent the virus from infecting human cells.
Usa virus covid-19 testing infection
UK researchers engineer antibodies from llamas against Covid-19 - pharmaceutical-technology.com - Britain
pharmaceutical-technology.com
53%
771
UK researchers engineer antibodies from llamas against Covid-19
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Researchers from the Rosalind Franklin Institute, Oxford University, Diamond Light Source and Public Health England in the UK have engineered antibodies obtained from llamas against Covid-19. In lab tests, the engineered antibodies were found to neutralise the SARS-CoV-2 virus, which causes Covid-19 infection.
Britain virus covid-19 testing
Covid-19: Synairgen embraces virtual clinical trials - pharmaceutical-technology.com
pharmaceutical-technology.com
50%
411
Covid-19: Synairgen embraces virtual clinical trials
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The Covid-19 pandemic has significantly upset clinical development. More than 1,000 clinical trials have been disrupted by the ongoing pandemic, primarily due to issues with enrolment and recruitment, according to GlobalData.
covid-19 testing pandemic patient
GSK partners with Medicago to develop plant-based Covid-19 vaccine - pharmaceutical-technology.com
pharmaceutical-technology.com
56%
555
GSK partners with Medicago to develop plant-based Covid-19 vaccine
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.GlaxoSmithKline (GSK) has partnered with Canadian biopharmaceutical firm Medicago to develop, assess and manufacture a plant-based adjuvanted Covid-19 vaccine candidate. As part of the collaboration, GSK’s pandemic adjuvant system will be combined with Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP), which mimic the novel coronavirus’ structure and enable identification by the immune system.
covid-19 testing pandemic vaccine
Oxford Covid-19 vaccine doses improve immune response in animals - pharmaceutical-technology.com
pharmaceutical-technology.com
63%
881
Oxford Covid-19 vaccine doses improve immune response in animals
could protect macaques against lung disease following a single immunisation. Currently, participants are being enrolled for the next phase of human trials, with the hope that an effective vaccine could be generated later this year.
virus testing vaccine infection
Avalon GloboCare to develop intranasal and oral Covid-19 vaccine - pharmaceutical-technology.com
pharmaceutical-technology.com
45%
915
Avalon GloboCare to develop intranasal and oral Covid-19 vaccine
As part of the collaboration, Avalon’s expertise and bio-manufacturing infrastructure and clinical study implementation resources will be leveraged along with BOKU professors scientific capabilities and laboratory expertise. BOKU professors have already created the approaches required to synthesise conjugate vaccines with an S-layer artificial viral envelope linked to a viral antigen.
covid-19 president testing vaccine
India’s CDRI gets approval for Phase III trial of Umifenovir to treat Covid-19 - pharmaceutical-technology.com - China - India - Russia
pharmaceutical-technology.com
59%
626
India’s CDRI gets approval for Phase III trial of Umifenovir to treat Covid-19
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Central Drug Research Institute (CDRI), a constituent lab of India-based Council of Scientific and Industrial Research (CSIR), has secured approval for carrying out Phase III trial for the use of Umifenovir in the treatment of Covid-19. In this randomised, double-blind, placebo-controlled trial, CDRI will test the efficacy, safety and tolerability of  Umifenovir.
China India Russia covid-19 testing patient
PDS Biotech and Farmacore partner to develop Covid-19 vaccine - pharmaceutical-technology.com - Brazil
pharmaceutical-technology.com
56%
811
PDS Biotech and Farmacore partner to develop Covid-19 vaccine
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.US-based immunotherapy company PDS Biotechnology has partnered with Brazilian biotechnology firm Farmacore Biotechnology to jointly develop a Covid-19 vaccine. The vaccine candidate, Versamune-CoV-2FC (PDS0204), is based on PDS Biotechnology’s immune-activating Versamune platform, integrating a recombinant fusion protein of SARS-CoV-2 developed by Farmacore to be recognised by the human immune system.
Brazil covid-19 testing vaccine
Daewoong finds niclosamide effective against Covid-19 in animal tests - pharmaceutical-technology.com - South Korea
pharmaceutical-technology.com
67%
913
Daewoong finds niclosamide effective against Covid-19 in animal tests
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.South Korea-based Daewoong Pharmaceutical has found that its anti-parasitic drug niclosamide removed SARS-CoV-2, the novel coronavirus that causes Covid-19, from lungs in animal tests. The company added that the drug completely cleared the infection in ferrets’ lung tissues and inhibited inflammation, according to Reuters.
South Korea covid-19 testing information Coronavirus
Celltrion’s Covid-19 antibody therapy reduces viral load in animal tests - pharmaceutical-technology.com - South Korea
pharmaceutical-technology.com
46%
968
Celltrion’s Covid-19 antibody therapy reduces viral load in animal tests
South Korea-based Celltrion Group has reported positive results from the preclinical tests of its Covid-19 antibody treatment, which led to a 100-fold decrease in the viral load of SARS-CoV-2.
South Korea covid-19 testing medicines
Israeli scientists say Gaucher’s disease drugs may help treat Covid-19 - pharmaceutical-technology.com - Usa - Israel
pharmaceutical-technology.com
44%
878
Israeli scientists say Gaucher’s disease drugs may help treat Covid-19
Scientists from the Israeli Institute for Biological Research (IIBR) claim that analogues of two drugs used for the treatment of Gaucher’s disease could be effective against Covid-19.
Usa Israel virus covid-19 testing Coronavirus
Doug Ford - Chris Mackie - London Covid - London COVID-19 testing centres see over 500 people in busiest day yet - globalnews.ca
globalnews.ca
35%
860
London COVID-19 testing centres see over 500 people in busiest day yet
The Middlesex London Health Unit is reporting the coronavirus testing centres saw their greatest number in visits since opening their doors.
Doug Ford Chris Mackie London Covid covid-19 coronavirus news Coronavirus testing Coronavirus
Rapid Micro Biosystems raises $120m: improving contamination testing in pharma - pharmaceutical-technology.com - state Massachusets
pharmaceutical-technology.com
67%
912
Rapid Micro Biosystems raises $120m: improving contamination testing in pharma
Massachusetts-based Rapid Micro Biosystems has closed a $120m financing round, led by the new investors Ally Bridge Group and Endeavour Vision. Existing investors, including  Bain Capital Life Sciences, Longitude Capital, Xeraya Capital and Asahi Kasei Medical, also participated in the funding round.
state Massachusets covid-19 testing pandemic vaccine
Inovio’s Covid-19 vaccine triggers immune responses in preclinical tests - pharmaceutical-technology.com - state Texas
pharmaceutical-technology.com
60%
766
Inovio’s Covid-19 vaccine triggers immune responses in preclinical tests
Inovio Pharmaceuticals has reported promising data from the preclinical studies of its Covid-19 vaccine candidate, IN0-480, in mice and guinea pigs.
state Texas virus covid-19 vaccine Coronavirus triggers
J&J signs Covid-19 vaccine manufacturing contract with Vibalogics - pharmaceutical-technology.com - Germany
pharmaceutical-technology.com
41%
181
J&J signs Covid-19 vaccine manufacturing contract with Vibalogics
Johnson & Johnson (J&J) has signed a deal with contract development and manufacturing organisation (CDMO) Vibalogics for the manufacture of clinical trial material for a Covid-19 vaccine candidate being developed by J&J unit Janssen Pharmaceutical.
Germany virus covid-19 testing vaccine
India’s CSIR proposes testing of sepsis treatment drug as Covid-19 vaccine - pharmaceutical-technology.com - India
pharmaceutical-technology.com
73%
734
India’s CSIR proposes testing of sepsis treatment drug as Covid-19 vaccine
The Council of Scientific and Industrial Research (CSIR) in India has proposed the testing of sepsis treatment drug as a vaccine for Covid-19.
India covid-19 testing vaccine patient
Eli Lilly - Eli Lilly signs Covid-19 drug development deal with Junshi Biosciences - pharmaceutical-technology.com - China
pharmaceutical-technology.com
74%
413
Eli Lilly signs Covid-19 drug development deal with Junshi Biosciences
Eli Lilly has signed an agreement with China-based biopharmaceutical firm Junshi Biosciences to jointly develop therapeutic antibodies to prevent and treat Covid-19.
Eli Lilly China covid-19 testing prevention infection
Atreca, BeiGene and IGM Biosciences to develop Covid-19 therapies - pharmaceutical-technology.com
pharmaceutical-technology.com
78%
303
Atreca, BeiGene and IGM Biosciences to develop Covid-19 therapies
Atreca, BeiGene and IGM Biosciences have partnered to identify, develop, and manufacture new immunoglobulin M (IgM) and immunoglobulin A (IgA) antibody therapeutics for Covid-19 infection.
covid-19 pandemic infection Coronavirus
Covid-19: The world embraces contact-tracing technology to fight the virus - livemint.com - Usa
livemint.com
64%
445
Covid-19: The world embraces contact-tracing technology to fight the virus
Covid-19 has killed more than 200,000 people and triggered a severe recession. Governments want to get people back to work, and a key part of this is contact-tracing technology that helps authorities track the virus and warn citizens who may be infected to stay home or get tested.
Usa covid-19 testing Government
Griffith University and IIL team up to develop Covid-19 vaccine - pharmaceutical-technology.com - India - Australia
pharmaceutical-technology.com
95%
558
Griffith University and IIL team up to develop Covid-19 vaccine
Griffith University in Australia has partnered with vaccines manufacturing company Indian Immunologicals (IIL) to develop a Covid-19 vaccine.
India Australia covid-19 testing vaccine Coronavirus
Beyond testing: the importance of antibodies in tackling Covid-19 - pharmaceutical-technology.com - Usa - Britain
pharmaceutical-technology.com
94%
200
Beyond testing: the importance of antibodies in tackling Covid-19
Antibody tests have been heralded as a crucial weapon in the battle against the Covid-19 pandemic. This has been a significant focus of the UK Government, which ordered 3.5m home tests at the end of March. The US has recently jumped on the bandwagon, with the FDA calling on manufacturers to submit emergency use authorisation applications for antibody tests, while the US National Institutes of Health will evaluate the tests’ performance.
Usa Britain virus covid-19 testing pandemic
MIT researchers in US advance Covid-19 vaccine into preclinical tests - pharmaceutical-technology.com - Usa - state Massachusets
pharmaceutical-technology.com
35%
614
MIT researchers in US advance Covid-19 vaccine into preclinical tests
A research team at the Massachusetts Institute of Technology (MIT) in the US have advanced a Covid-19 vaccine candidate into preclinical tests in animal models.
Usa state Massachusets virus covid-19 testing vaccine
Real-world evidence the most impactful emerging technology in COVID-19 management: Poll - pharmaceutical-technology.com
pharmaceutical-technology.com
49%
636
Real-world evidence the most impactful emerging technology in COVID-19 management: Poll
New-age emerging technologies are projected to have a significant impact on managing the coronavirus pandemic (COVID-19).
covid-19 testing patient
RedHill Biopharma partners with NIAID for potential Covid-19 drug - pharmaceutical-technology.com - Usa - Israel
pharmaceutical-technology.com
73%
247
RedHill Biopharma partners with NIAID for potential Covid-19 drug
Israel-based RedHill Biopharma has partnered with the US National Institute of Allergy and Infectious Diseases (NIAID) to study its RHB-107 (upamostat, WX-671) drug candidate in non-clinical tests for the treatment of Covid-19.
Usa Israel covid-19 pneumonia testing patient
University of Georgia’s Covid-19 vaccine shows promise in test models - pharmaceutical-technology.com - state Iowa - Georgia
pharmaceutical-technology.com
88%
145
University of Georgia’s Covid-19 vaccine shows promise in test models
A Covid-19 vaccine candidate developed by a research team at the University of Georgia (UGA) College of Veterinary Medicine has shown promise in test models.
state Iowa Georgia virus covid-19 testing vaccine
Applied DNA supplies Covid-19 vaccine candidates for preclinical tests - pharmaceutical-technology.com - Italy
pharmaceutical-technology.com
63%
169
Applied DNA supplies Covid-19 vaccine candidates for preclinical tests
Applied DNA Sciences has shipped five Covid-19 LinearDNA vaccine candidates to Italy-based Takis Biotech for preclinical testing in animals.
Italy covid-19 testing vaccine DNA
Social Distancing Can Test If Technology Could Solve the Loneliness Epidemic - acl.gov - Usa
acl.gov
88%
240
Social Distancing Can Test If Technology Could Solve the Loneliness Epidemic
Stat (April 7 )
Usa testing patient strain Coronavirus
Celltrion identifies antibody candidates against Covid-19 - pharmaceutical-technology.com
pharmaceutical-technology.com
50%
828
Celltrion identifies antibody candidates against Covid-19
Celltrion Group has completed a neutralisation test and identified the antibody candidates that showed the most promise for neutralising the novel coronavirus, SARS-CoV-2, which causes Covid-19.
covid-19 testing crisis Coronavirus
Australia’s UQ Covid-19 vaccine candidate advances to preclinical tests - pharmaceutical-technology.com - Australia - Netherlands
pharmaceutical-technology.com
45%
757
Australia’s UQ Covid-19 vaccine candidate advances to preclinical tests
The University of Queensland (UQ) in Australia has progressed its Covid-19 vaccine candidate into preclinical testing stage.
Australia Netherlands virus covid-19 testing vaccine
FDA authorises Emory University to trial antiviral for Covid-19 - pharmaceutical-technology.com - Usa
pharmaceutical-technology.com
69%
336
FDA authorises Emory University to trial antiviral for Covid-19
Emory University subsidiary DRIVE has received the US Food and Drug Administration (FDA) approval for its investigational new drug application of antiviral compound EIDD-2801 to treat Covid-19.
Usa covid-19 testing Ebola prevention
University of Bristol, Imophoron to test Covid-19 vaccine candidates - pharmaceutical-technology.com - city Bristol
pharmaceutical-technology.com
73%
182
University of Bristol, Imophoron to test Covid-19 vaccine candidates
The University of Bristol and spin-out firm Imophoron are set to assess Covid-19 vaccine candidates in-vivo in a pre-clinical programme.
city Bristol covid-19 testing vaccine
Different paths to the same destination: screening for Covid-19 - pharmaceutical-technology.com - South Korea - Britain
pharmaceutical-technology.com
78%
656
Different paths to the same destination: screening for Covid-19
Over the course of the current Covid-19 crisis, the importance of reliable, accessible testing to screen for the disease has become increasingly apparent. South Korea, where tests for the disease were made promptly and readily available when the outbreak first hit, has had a drastically lower death rate than counties which have responded less promptly. Only 174 Covid-19 fatalities have been recorded in South Korea out of over 10,000 recorded cases, compared to 2,921 deaths in the UK out of nearly 34,000 recorded cases.
South Korea Britain virus covid-19 testing infection
Australia’s CSIRO starts first stage of coronavirus vaccine testing - pharmaceutical-technology.com - Usa - Britain - Australia - city Oxford
pharmaceutical-technology.com
93%
571
Australia’s CSIRO starts first stage of coronavirus vaccine testing
The Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Australia has begun the first stage of testing of two potential Covid-19 vaccines.
Usa Britain Australia city Oxford covid-19 testing vaccine Coronavirus
Benjamin Netanyahu - Israeli scientists progress to animal testing of Covid-19 vaccine prototype - pharmaceutical-technology.com - Israel - city Jerusalem
pharmaceutical-technology.com
89%
505
Israeli scientists progress to animal testing of Covid-19 vaccine prototype
The Israel Institute for Biological Research (IIBR) has made ‘significant’ progress in creating a vaccine prototype and preparations are underway for animal testing, said Prime Minister Benjamin Netanyahu.
Benjamin Netanyahu Israel city Jerusalem covid-19 testing vaccine Coronavirus
Exscientia forms UK-US partnership to screen possible Covid-19 drugs - pharmaceutical-technology.com - Usa - Britain - state California - city Oxford
pharmaceutical-technology.com
89%
905
Exscientia forms UK-US partnership to screen possible Covid-19 drugs
Artificial intelligence (AI) drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with the UK’s national synchrotron facility Diamond Light Source and University of Oxford across the Atlantic Ocean to include California-based Scripps Research’s Calibr and focus on Covid-19 research.
Usa Britain state California city Oxford covid-19 testing RNA bill
Sorrento forms alliance for preclinical testing of Covid-19 drugs - pharmaceutical-technology.com - Usa - state Texas - county Branch - county Galveston
pharmaceutical-technology.com
56%
841
Sorrento forms alliance for preclinical testing of Covid-19 drugs
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates
Usa state Texas county Branch county Galveston covid-19 experts testing Coronavirus
Influenza drug Favipiravir being tested to treat COVID-19 - pharmaceutical-technology.com - China - Japan - Usa
pharmaceutical-technology.com
58%
948
Influenza drug Favipiravir being tested to treat COVID-19
The influenza antiviral favipiravir was tested in clinical trials with COVID-19 patients in China and showed a shorter viral clearance time than the control group that received the anti-HIV combo lopinavir/ritonavir. Credit: Antipina Daria via Shutterstock.
China Japan Usa covid-19 testing RNA patient
J&J partners with BARDA to commit $1bn to Covid-19 vaccine development - pharmaceutical-technology.com - Usa
pharmaceutical-technology.com
57%
671
J&J partners with BARDA to commit $1bn to Covid-19 vaccine development
Johnson & Johnson (J&J) has expanded its partnership with the US Department for Health and Human Service (HSS)’s Biomedical Advanced Research and Development Authority (BARDA) to commit more than $1bn to co-fund research and development (R&D), as well as clinical testing, of Covid-19 vaccines.
Usa covid-19 testing vaccine
Grifols teams up with US to test plasma therapy for Covid-19 - pharmaceutical-technology.com - Usa - Spain - state North Carolina - county Clayton
pharmaceutical-technology.com
44%
479
Grifols teams up with US to test plasma therapy for Covid-19
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates
Usa Spain state North Carolina county Clayton hospital covid-19 pandemic
Covid-19: CEL-SCI to develop therapy; Soligenix works on vaccine - pharmaceutical-technology.com - Georgia
pharmaceutical-technology.com
85%
244
Covid-19: CEL-SCI to develop therapy; Soligenix works on vaccine
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates
Georgia virus covid-19 testing
Hoth Therapeutics forms JV to develop Covid-19 vaccine - pharmaceutical-technology.com - state Massachusets
pharmaceutical-technology.com
82%
935
Hoth Therapeutics forms JV to develop Covid-19 vaccine
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates
state Massachusets hospital covid-19 testing
Coronavirus outbreak: Countries that have tested negative - pharmaceutical-technology.com - China - city Wuhan
pharmaceutical-technology.com
67%
844
Coronavirus outbreak: Countries that have tested negative
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates
China city Wuhan covid-19 testing
Covid-19 death toll tops 7,100; WHO calls for increased testing - pharmaceutical-technology.com - China
pharmaceutical-technology.com
38%
450
Covid-19 death toll tops 7,100; WHO calls for increased testing
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates
China covid-19 death testing
COVID-19
United States
United States
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
India
India
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
Brazil
Brazil
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
United Kingdom
United Kingdom
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
Russia
Russia
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
Detail statistic
4 Daily Habits that Keep Holding the Best of Us Back (Year After Year)
'Sullivan's Crossing' Season 3 - The CW TV Show Renewal Status & Returning Cast Revealed!
The Power of Finding Hidden Opportunities in Our Problems
Chest Heart & Stroke Scotland and Scottish Ambulance Service launch F.A.S.T. campaign to highlight stroke signs and symptoms
Legendary TV presenter dies aged 78 after long illness as tributes are paid to ‘a force beyond nature’
How to entertain yourself when you stuck inside due to a pandemic
About Us

Covid-19.rehab - the latest news concerning the spread of the SARS-CoV-2 coronavirus (formerly 2019-nCoV), as well as the infectious disease that it causes COVID-19, in separate countries and in the world as a whole. Current news on the topic of coronavirus SARS-CoV-2. Quarantine, pandemic 2020, epidemic: what is it, when will it come to end, precautions and how to protect yourself from this disease. The most honest news, no fakes! To keep up with the latest news, stay tuned for updates on the site! Every day we will collect news and statistics on coronavirus from around the world for you to be aware of this topic.

Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic

Categories
Info
For advertisers
Add Post

©2024. All rights reserved.

DMCA